Here's hoping that 1) The safety and dosage data are good, accurate and complete and 2) That the people with COVID who are being tested in the dosage stages have some measurable improvement in the conditions.
IF those data look good, if Diwan is smart he gets into some serious talks with a US Pharma company about setting up a Phase II either in India right away, or getting the FDA the Indian data package for that Phase I and applying for an IND here. If this does look like it could work, then perhaps a partnership would be in order?